Device and procedure for the identification of pharmaceutical containers
Inventors
LOPEZ-BELMONTE ENCINA, Javier • CRISTOBAL GIL, Jose • CASADO URTIAGA, Cristina
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
An identification device and procedure for pharmaceutical containers comprising at least one means of marking at least one secured identification code on each of the containers, characterised in that the device comprises at least one inkjet system configured to print the identification code on at least one surface of the moving container with at least one ink which exhibits visible fluorescence when radiated with ultraviolet (UV) radiation, and whose drying time is 1 to 3 seconds or less than about 3 seconds.
Core Innovation
The invention relates to a marking system for marking pharmaceutical containers with at least one secured identification code. The system applies at least one code to containers using at least one security ink, where the code is either not readily visible to the unaided human eye until irradiated with ultraviolet (UV) or infra-red (IR) radiation thereby creating fluorescence in the visible light spectrum, or visible only in the UV or infra-red (IR) frequencies of the spectrum.
The system includes operation stations for loading containers, marking containers with the secured identification code using the security ink, reading and verification of the identification code, and sorting containers to an exit station or a rejection station. The system further comprises a rotating platform or turntable comprising plural receptacles, an inverter upstream of the loading station, a halting device to halt loading of the containers, a container load sensing system, container detection means, a container transfer station, and/or a code sealing station.
In the method aspect, the invention includes printing the identification code by means of an inkjet system on at least one surface of the containers using the security ink. The process can include sealing the marked containers, verifying the secured identification code, rotating and inverting containers, routing rejected marked containers to one or more collection containers, and maintaining a sterile environment.
Claims Coverage
The document includes four independent claims. Across these independent claims, the coverage centers on applying a secured identification code with a security ink that is UV/IR-visible or UV-induced fluorescence, combined with automated handling, reading and verification, and sorting or collection, with variants adding sealing, sterile environment operation, rejection handling, and halting in response to detected errors.
Secured identification code with UV/IR-visible or UV-induced fluorescence ink
A marking system for marking pharmaceutical containers with at least one secured identification code, where the code is formed from at least one security ink and is either not readily visible to the unaided human eye until irradiated with ultraviolet (UV) or infra-red (IR) radiation thereby creating fluorescence in the visible light spectrum, or visible only in the ultraviolet (UV) or infra-red (IR) frequencies of the spectrum.
Operational stations for loading, marking, reading/verification, and sorting to exit or rejection
A system comprising at least a loading station, a marking station for marking containers with a secured identification code using a security ink, a reading station for reading and verification of the identification code, and a sorting station for directing marked containers to an exit station or to a rejection station.
Rotating platform/turntable with inverter, sensing, detection, transfer, halting, and optional code sealing
The system further comprises a rotating platform or turntable comprising plural receptacles; an inverter upstream of the loading station; a halting device to halt loading of the containers; a container load sensing system; container detection means; a container transfer station; and/or a code sealing station.
Method of marking with inkjet printing of UV/fluorescent or UV/IR-only secured code
A method of marking pharmaceutical containers with at least one secured identification code comprising printing the identification code by means of an inkjet system on at least one surface of the containers with at least one security ink exhibiting visible fluorescence when radiated with ultraviolet (UV) radiation, or only visible in the UV or IR light spectrum.
Verification and sealing during handling and platform rotation
The method further comprises sealing the secured identification code(s) onto the marked containers and verifying the secured identification code(s), including rotating the platform to move the marked containers.
Automated container handling for rejection routing and collection while in a sterile environment
The method further comprises inverting containers prior to marking; unloading marked containers onto a conveyor; rotating the platform to move rejected marked containers to an exit position aligned with a rejection station; ejecting rejected marked containers into one or more collection containers; and performing the process in a sterile environment.
Halting operation in response to detected error on marked containers
The method further comprises halting operation of the system in direct or indirect response to an error detected on the marked container(s).
Security ink performance characteristics for adherence, drying time, UV visibility, fluorescence, and thermal degradation resistance
A method of marking pharmaceutical containers with at least one secured identification code by printing the identification code using an inkjet system on at least one surface of the containers with at least one security ink having good adherence to refrigerated containers at temperatures of approximately 15°C and up to ambient temperature; a drying time of about 3 seconds or less; UV visibility within about 10 to about 400 nm; fluorescence emitting visible light radiation when irradiated with excitation radiation within a UV wavelength of within about 320 to about 400 nm; resistance to degradation when exposed to a temperature above 120°C for at least 20 minutes; and comprising at least one luminescent colorant and at least one solvent, with at least one solubilizing agent and/or at least one binding resin.
Across the independent claims, the invention covers marking pharmaceutical containers with a secured identification code made from a security ink whose visibility is UV/IR-dependent, and integrating this marking with container-handling stations that enable loading, marking, reading and verification, and sorting to exit versus rejection. The method variants further include inkjet printing, sealing and verification, rotating and inverting handling, sterile environment operation, rejection collection, and halting in response to errors.
Stated Advantages
Enables reading and verification of the identification code and sorting of marked containers to an exit station or a rejection station.
Provides secured identification codes that are not readily visible to the unaided human eye until irradiated with UV/IR to create fluorescence in the visible light spectrum or that are visible only in UV/IR frequencies.
Supports halting of operation in direct or indirect response to an error detected on marked containers.
Supports performing the process in a sterile environment.
Security ink is characterized as having good adherence to refrigerated containers, a drying time of about 3 seconds or less, specified UV visibility and excitation/fluorescence behavior, and resistance to degradation after exposure to elevated temperatures for at least 20 minutes.
Documented Applications
Marking pharmaceutical containers including syringes, vials, cartridges, ampoules, capsules, single-dose devices, inhalers, bottles, and bags with secured identification codes for subsequent automated reading, verification, and routing to exit or rejection.
Marking pharmaceutical containers using an inkjet system that prints a UV/IR-visible secured identification code, with optional sealing and verification, and including rejected-container ejection into collection containers, performed in a sterile environment.
Interested in licensing this patent?